IP Library Granted Patent US 7,801,585
Granted Patent B1
US 7,801,585 · App. 10/856,632 · Granted Sep 21, 2010

System for analyzing and treating abnormality of human and animal tissues

Assignee: NewLife Sciences LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,801,585
App. No.
10/856,632
Granted
Sep 21, 2010
Kind
B1
Abstract

A system for analyzing and treating abnormality of human and animal tissues includes a subsystem for modulating a magnetic field, having a strength of between about 0.1 gauss and 4 Tesla, across an EM spectrum of between about 1 Hz and about 1 GHz. The system also includes a subsystem for subjecting the tissue to the modulated magnetic field and further includes a subsystem for measuring resultant EMR peaks of a signal emitted by the tissue, in which each peak represents a potential in-phase or out-of-phase EMR relative to a normal signal of the tissue. The system further includes a subsystem for generating and applying to the tissue a wave form and resonance substantially inverse to that of out-of-phase resonances of the tissue signal to increase or nullify EMR peaks of the signal associated with an abnormality.

Claims (28)

1. A system for analyzing and treating abnormality to human and animal tissues, comprising:

(a) means for modulating a magnetic field having a strength, of between about 100 gauss and about 4 Tesla, across an RF spectrum of between about 1 MHz and about 1 GHz;

(b) means for subjecting said tissue to said modulated magnetic field;

(c) means for re-iteratively measuring resultant electron magnetic resonance (EMR) peaks of a signal emitted by said tissue, in which each peak of said EMR peaks represent an out-phase EMR; and

(d) means for generating and re-iteratively applying to said tissue a waveform substantially inverse to that of said out-of-phase resonance of said EMR tissue signal, to thereby increase, decrease or nullify abnormal EMR peaks of said signal associated with said abnormality of said tissue.

2. The system as recited in claim 1 in which said magnetic resonance peaks comprise peaks of electron paramagnetic resonance.

3. The system as recited in claim 1 in which:

said subjecting means (b) comprises a stimuli module; and

said measuring means comprises a measurement module.

4. The system as recited in claim 3 , further comprising:

a communications module of a functional management unit (FMU).

5. The system as recited in claim 4 in which said generating means (d) comprises:

local treatment inputs including pads having electrodes embedded therein.

6. The system as recited in claim 3 in which said measurement module comprises a low-order band pass filter.

7. The system as recited in claim 6 in which said measurement module comprises means for stochastic modeling and self-learning.

8. The system as recited in claim 5 in which said generating means (d) comprises a multi-electrode unit having variable waveform parameters.

9. The system as recited in claim 8 in which said measurement module comprises:

means for stochastic modeling and self-learning.

10. The system as recited in claim 4 in which said communication module comprises a personal computer.

11. The system as recited in claim 10 , further comprising:

an RF interface between said personal computer and said stimuli and measurement modules.

12. A system for analyzing and treating abnormality to human and animal tissues, comprising:

means for modulating a magnetic field having a strength, of between about 100 gauss and about 4 Tesla, across an RF spectrum of between about 1 MHz and about 1 GHz;

means for subjecting said tissue to said modulated magnetic field;

means for re-iteratively measuring resultant electron magnetic resonance (EMR) peaks of a signal emitted by said tissue, in which each peak of said EMR peaks represent an out-phase EMR, the means for measuring including a low-order band pass filter and means for stochastic modeling and self-learning, said magnetic resonance peaks comprising peaks of electron paramagnetic resonance;

means for generating and re-iteratively applying to said tissue a waveform substantially inverse to that of said out-of-phase resonance of said EMR tissue signal, to thereby increase, decrease or nullify abnormal EMR peaks of said signal associated with said abnormality of said tissue, the means for generating including local treatment inputs including pads having electrodes embedded therein and a multi-electrode unit having variable waveform parameters;

a communications module of a functional management unit (FMU); and

an RF interface between said subjecting means and said measuring means.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2026
From: TRUERELIEF, LLC
To: GLS HOLDINGS, LLC
Reel/Frame 074862/0970 →
SECURITY INTEREST Recorded Apr 21, 2026
From: TRUERELIEF, LLC
To: MEDCAP PARTNERS, LLC
Reel/Frame 074431/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: NEWLIFE SCIENCES LLC
To: TRUERELIEF, LLC
Reel/Frame 047711/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 11, 2007
From: WEINSTOCK, RONALD J.
To: NEWLIFE SCIENCES, LLC
Reel/Frame 019279/0551 →
Continuity (1)
Provisional Application 6047484300 · Jun 2, 2003